Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
Authors:
Open Access
- 15 October 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (20) , 6807-6820
Abstract
Purpose: According to some studies, susceptibility of cells to anticancer drug-induced apoptosis is markedly inhibited by targeted deletion of genes encoding apoptotic protease activating factor 1 (Apaf-1) or certain caspases. Information about levels of these polypeptides in common cancer cell types and any possible correlation with drug sensitivity in the absence of gene deletion is currently fragmentary.Keywords
This publication has 94 references indexed in Scilit:
- Cell DeathCell, 2004
- Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in VitroJournal of Biological Chemistry, 2003
- Apoptosome-independent Pathway for ApoptosisJournal of Biological Chemistry, 2003
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Differences in Expression of Pro-Caspases in Small Cell and Non-small Cell Lung CarcinomaBiochemical and Biophysical Research Communications, 1999
- Characterization of Caspase Processing and Activation in HL-60 Cell Cytosol Under Cell-free ConditionsJournal of Biological Chemistry, 1999
- STAT-1-Independent Upregulation of FADD and Procaspase-3 and -8 in Cancer Cells Treated with Cytotoxic DrugsBiochemical and Biophysical Research Communications, 1999
- Exploring the new world of the genome with DNA microarraysNature Genetics, 1999
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994